litlas
Log inCreate account

Brigitte Schlegelberger

Active 1986–2024

142
Papers
26,706
Citations
96
h-index
141
i10-index

Citations

Citations per year for Brigitte Schlegelberger1979: 3 citations1985: 1 citations1987: 1 citations1993: 3 citations1994: 2 citations1995: 2 citations1996: 9 citations1997: 14 citations1998: 33 citations1999: 53 citations2000: 76 citations2001: 101 citations2002: 112 citations2003: 106 citations2004: 124 citations2005: 142 citations2006: 165 citations2007: 187 citations2008: 184 citations2009: 208 citations2010: 230 citations2011: 296 citations2012: 287 citations2013: 319 citations2014: 316 citations2015: 253 citations2016: 285 citations2017: 250 citations2018: 191 citations2019: 717 citations2020: 765 citations2021: 701 citations2022: 512 citations2023: 359 citations2024: 542 citations2025: 212 citations2026: 3 citations1980–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1988–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,960 citing papers, 26.2% of this breakdownGermany: 1,414 citing papers, 12.5% of this breakdownUnited Kingdom: 857 citing papers, 7.6% of this breakdownItaly: 608 citing papers, 5.4% of this breakdownChina: 600 citing papers, 5.3% of this breakdownFrance: 568 citing papers, 5% of this breakdownNetherlands: 420 citing papers, 3.7% of this breakdownSpain: 341 citing papers, 3% of this breakdownCanada: 335 citing papers, 3% of this breakdownJapan: 318 citing papers, 2.8% of this breakdownAustralia: 250 citing papers, 2.2% of this breakdownSwitzerland: 237 citing papers, 2.1% of this breakdown
0%26.2%Other 21.2%

Institutions

Fields

  • Medicine62.9%
  • Biochemistry, Genetics and Molecular Biology29.4%
  • Immunology and Microbiology4.7%
  • Agricultural and Biological Sciences0.6%
  • Chemistry0.5%
  • Neuroscience0.4%
  • Other1.5%

Topics

  • Acute Myeloid Leukemia Research12.8%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.8%
  • Chronic Myeloid Leukemia Treatments3.8%
  • Acute Lymphoblastic Leukemia research3.1%
  • Epigenetics and DNA Methylation3%
  • Lymphoma Diagnosis and Treatment2.6%
  • Other70.9%

Coauthors

All papers

Open in search
  1. Oncogene-induced senescence as an initial barrier in lymphoma development

    Authors: Melanie Braig, Soyoung Lee, Christoph Loddenkemper, Cornelia Rudolph, Antoine H.F.M. Peters, Brigitte Schlegelberger, Harald Stein, Bernd Dörken, Thomas Jenuwein, Clemens A. Schmitt - Nature 2005 cited by 1,206

  2. Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

    Authors: Christian Braun, Kaan Boztuǧ, Anna Paruzynski, Maximilian Witzel, Adrian Schwarzer, Michael Rothe, Ute Modlich, Rita Beier, Gudrun Göhring, Doris Steinemann, Raffaele Fronza, Claudia R. Ball, Reinhard Haemmerle, Sonja Naundorf, Klaus Kühlcke, Martina Rose, Chris Fraser, Liesl Mathias, Rudolf Ferrari, Miguel R. Abboud, Waleed Al–Herz, Irina Kondratenko, László Maródi, Hanno Glimm, Brigitte Schlegelberger, Axel Schambach, Michael H. Albert, Manfred Schmidt, Christof von Kalle, Christoph Klein - Science Translational Medicine 2014 cited by 555

  3. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

    Authors: Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Sabine Käyser, Veronica Teleanu, H. Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, Peter Paschka, Gerhard Held, Marie von Lilienfeld‐Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Peter Lichter, Konstanze Döhner, Hartmut Döhner - Blood 2011 cited by 678

  4. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

    Authors: Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, Piroska Klement, Johannes Schiller, Christian Kandziora, Lothar Hambach, Michael Stadler, Christian Koenecke, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Konstantin Büttner, Bennet Heida, Sabrina Klesse, Anuhar Chaturvedi, Arnold Kloos, Gudrun Göhring, Brigitte Schlegelberger, Verena I. Gaidzik, Lars Bullinger, Walter Fiedler, Albert Heim, Iyas Hamwi, Matthias Eder, Jürgen Krauter, Richard F. Schlenk, Peter Paschka, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Michael Heuser - Blood 2018 cited by 301

  5. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

    Authors: Sushree Sangita Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca Voss, Emilia J. Kozyra, Amina Szvetnik, Peter Noellke, Michael Dworzak, Jan Starý, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Barbara De Moerloose, Albert Català, Krisztián Kállay, Dominik Turkiewicz, Henrik Hasle, Jochen Buechner, Kirsi Jahnukainen, Marek Ussowicz, Sophia Polychronopoulou, Owen Smith, Oksana Fabri, Shlomit Barzilai, Válerie de Haas, Irith Baumann, Stephan Schwarz‐Furlan, the European Working Group of MDS in Children (EWOG-MDS), Jan Starý, Barbara De Moerloose, Krisztián Kállay, Owen Smith, Válerie de Haas, Gudrun Göhring, Charlotte M. Niemeyer, Karin Nebral, Ingrid Simonitsch-Kluppp, Pascale De Paepe, Nadine Van Roy, Vít Campr, Zuzana Zemanová, Erik Clasen‐Linde, Tine Plesner, Brigitte Schlegelberger, Martina Rudelius, Kalliopi N. Manola, Kalliopi Stefanaki, Judit Csomor, Hajnalka Andrikovics, David R. Betts, Maureen J. O’Sullivan, Yaniv Zohar, Marta Jeison, Rita De Vito, Francesco Pasquali, Jadwiga Małdyk, Olga Haus, Helena Alaiz, Paula Kjöllerström, Luís Mascarenhas‐Lemos, Ivana Boďová, Martin Čermák, Lukáš Plank, Barbara Gazić, Marko Kavčič, Helena Podgornik, Margarita Llavador Ros, José Cervera, Carole Gengler, Joëlle Tchinda, Berna Beverloo, Roos J. Leguit, Marena R. Niewisch, Martin G. Sauer, Birgit Burkhardt, Peter Lang, Peter Bader, Rita Beier, Ingo Müller, Michael H. Albert, Roland Meisel, Ansgar Schulz, Gunnar Cario, Pritam Kumar Panda, Julius Wehrle, Shinsuke Hirabayashi, Marta Derecka, Robert Durruthy-Durruthy, Gudrun Göhring, Ayami Yoshimi‐Noellke, Manching Ku, Dirk Lebrecht, Miriam Erlacher, Christian Flotho, Brigitte Strahm, Charlotte M. Niemeyer, Marcin W. Włodarski - Nature Medicine 2021 cited by 168

  6. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Authors: for the SAKK and the German CML Study Group, Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele, Markus Pfirrmann, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, C. Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Dominik Heim, Tim H. Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Marcus Müller, Sabine Jeromin, Ulrike Proetel, Katharina Kohlbrenner, Astghik Voskanyan, Sébastien Rinaldetti, Wolfgang Seifarth, Birgit Spieß, Leopold Balleisen, M-E Goebeler, Mathias Hänel, Anthony D. Ho, Jolanta Dengler, Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 cited by 339

  7. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

    Authors: Marcin W. Włodarski, Shinsuke Hirabayashi, Víctor Manuel López Pastor, Jan Starý, Henrik Hasle, Riccardo Masetti, Michael Dworzak, Markus Schmugge, Marry van den Heuvel‐Eibrink, Marek Ussowicz, Barbara De Moerloose, Albert Català, Owen Smith, Petr Sedláček, Arjan C. Lankester, Marco Zecca, Victoria Bordon, Susanne Matthes‐Martin, Jonas Abrahamsson, J. Kühl, Karl-Walter Sykora, Michael H. Albert, Bartlomiej Przychodzien, Jaroslaw P. Maciejewski, Stephan Schwarz, Gudrun Göhring, Brigitte Schlegelberger, Annamária Cseh, Peter Noellke, Ayami Yoshimi, Franco Locatelli, Irith Baumann, Brigitte Strahm, Charlotte M. Niemeyer - Blood 2015 cited by 388

  8. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

    Authors: Stefan Stein, Marion Ott, Stephan Schultze‐Strasser, Anna Jauch, Barbara Burwinkel, Andrea Kinner, Manfred Schmidt, Alwin Krämer, Joachim Schwäble, Hanno Glimm, Ulrike Koehl, Carolin Preiss, Claudia R. Ball, Hans Martin, Gudrun Göhring, Kerstin Schwarzwaelder, Wolf-Karsten Hofmann, Kadin Karakaya, Sandrine Tchatchou, Rongxi Yang, Petra Reinecke, Klaus Kühlcke, Brigitte Schlegelberger, Adrian J. Thrasher, Dieter Hoelzer, Reinhard Seger, Christof von Kalle, Manuel Grez - Nature Medicine 2010 cited by 784

  9. Monitoring of Minimal Residual Disease in NPM1 -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

    Authors: Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen, Florian Tschürtz, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Shiva Onken, Karina Eiwen, Marianne Habdank, Daniela Späth, Michael Lübbert, Mohammed Wattad, Thomas Kindler, Helmut R. Salih, Gerhard Held, David Nachbaur, Marie von Lilienfeld‐Toal, Ulrich Germing, Detlef Haase, H.‐G. Mergenthaler, Jürgen Krauter, Arnold Ganser, Gudrun Göhring, Brigitte Schlegelberger, Hartmut Döhner, Konstanze Döhner - Journal of Clinical Oncology 2011 cited by 394

  10. Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

    Authors: Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter, Stefan Fröhling, Andrea Corbacioglu, Lars Bullinger, Marianne Habdank, Daniela Späth, Michael Morgan, Axel Benner, Brigitte Schlegelberger, Gerhard Heil, Arnold Ganser, Hartmut Döhner - New England Journal of Medicine 2008 cited by 1,622

  11. Guiding the global evolution of cytogenetic testing for hematologic malignancies

    Authors: Yassmine Akkari, Linda B. Baughn, Adrian M. Dubuc, Adam C. Smith, Mar Mallo, Paola Dal Cin, María Díez‐Campelo, Marta S. Gallego, Isabel Granada, D. Haase, Brigitte Schlegelberger, Irma Slavutsky, Cristina Mecucci, Ross L. Levine, Robert P. Hasserjian, Françesc Solé, Brynn Levy, Xinjie Xu - Blood 2022 cited by 85

  12. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

    Authors: Sabine Käyser, Konstanze Döhner, Jürgen Krauter, Claus‐Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld‐Toal, Sibylla Wilhelm, Andrea Kündgen, Katharina S. Götze, Mathias Rummel, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Manuela Zucknick, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, for the German-Austrian AMLSG - Blood 2010 cited by 485

  13. TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

    Authors: Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Gudrun Göhring, Anette Hedlund, Robert Hast, Brigitte Schlegelberger, Anna Porwit, Eva Hellström‐Lindberg, Ghulam J. Mufti - Journal of Clinical Oncology 2011 cited by 460

  14. Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Authors: Petter Woll, Una Kjällquist, Onima Chowdhury, Helen Doolittle, David C. Wedge, Supat Thongjuea, Rikard Erlandsson, Mtakai Ngara, Kristina Anderson, Qiaolin Deng, Adam J. Mead, Laura Stenson, Alice Giustacchini, Sara Duarte, Eleni Giannoulatou, Stephen Taylor, Mohsen Karimi, Christian Scharenberg, Teresa Mortera‐Blanco, Iain C. Macaulay, Sally‐Ann Clark, Ingunn Dybedal, Dag Josefsen, Pierre Fenaux, Peter Hokland, Mette Skov Holm, Mario Cazzola, Luca Malcovati, Sudhir Tauro, David Bowen, Jacqueline Boultwood, Andrea Pellagatti, John E. Pimanda, Ashwin Unnikrishnan, Paresh Vyas, Gudrun Göhring, Brigitte Schlegelberger, Magnus Tobiasson, Gunnar Kvalheim, Stefan N. Constantinescu, Claus Nerlov, Lars Nilsson, Peter J. Campbell, Rickard Sandberg, Elli Papaemmanuil, Eva Hellström‐Lindberg, Sten Linnarsson, Sten Eirik W. Jacobsen - Cancer Cell 2014 cited by 320

  15. Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    Authors: Tim Ripperger, Stefan Bielack, Arndt Borkhardt, Ines B. Brecht, Birgit Burkhardt, Gabriele Calaminus, Klaus‐Michael Debatin, Hedwig E. Deubzer, Uta Dirksen, Cornelia Eckert, Angelika Eggert, Miriam Erlacher, Gudrun Fleischhack, Michael C. Frühwald, Astrid Gnekow, Gudrun Goehring, Norbert Graf, Helmut Hanenberg, Julia Hauer, Barbara Hero, Simone Hettmer, Katja von Hoff, Martin A. Horstmann, Juliane Hoyer, Thomas Illig, Peter Kaatsch, Roland Kappler, Kornelius Kerl, Thomas Klingebiel, Udo Kontny, Uwe Kordes, Dieter Körholz, Ewa Kościelniak, Christof M. Kramm, Michaela Kuhlen, Andreas E. Kulozik, Britta Lamottke, Ivo Leuschner, Dietmar Lohmann, Andrea Meinhardt, Markus Metzler, Lüder Hinrich Meyer, Olga Moser, Michaela Nathrath, Charlotte M. Niemeyer, R. Nustede, Kristian W. Pajtler, Claudia Paret, Mareike Rasche, Dirk Reinhardt, Olaf Rieß, Alexandra Russo, Stefan Rutkowski, Brigitte Schlegelberger, Dominik T. Schneider, Reinhard Schneppenheim, Martin Schrappe, Christopher Schroeder, Dietrich von Schweinitz, Thorsten Simon, Monika Sparber‐Sauer, Claudia Spix, Martin Stanulla, Doris Steinemann, Brigitte Strahm, Petra Temming, Kathrin Thomay, André O. von Bueren, Peter Vorwerk, Olaf Witt, Marcin W. Włodarski, Willy Wössmann, Martin Zenker, Stefanie Zimmermann, Stefan M. Pfister, Christian P. Kratz - American Journal of Medical Genetics Part A 2017 cited by 283

  16. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

    Authors: Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil, Daniela Weber, Peter Paschka, J. Hahn, Till Wallrabenstein, B Kolbinger, C.-H. Köhne, H. -A. Horst, Peter Brossart, Gerhard Held, Andrea Kündgen, Mark Ringhoffer, Katharina S. Götze, Mathias Rummel, Moritz Gerstung, Peter J. Campbell, Johann M. Kraus, Hans A. Kestler, Felicitas Thol, Michael Heuser, Brigitte Schlegelberger, Arnold Ganser, Lars Bullinger, Richard F. Schlenk, Konstanze Döhner, Hartmut Döhner, for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) - Leukemia 2016 cited by 283

  17. Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells

    Authors: R. Buurman, Engin Gürlevik, Vera Schäffer, Marlies Eilers, Maria Sandbothe, Hans Kreipe, Ludwig Wilkens, Brigitte Schlegelberger, Florian Kühnel, Britta Skawran - Gastroenterology 2012 cited by 212

  18. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia

    Authors: Jonathan Lukas Lühmann, Marie Stelter, Marie Wolter, J. McA. Kater, Jana Lentes, Anke K. Bergmann, Maximilian Schieck, Gudrun Göhring, Anja Möricke, Gunnar Cario, Markéta Žaliová, Martin Schrappe, Brigitte Schlegelberger, Martin Stanulla, Doris Steinemann - Cancers 2021 cited by 59

  19. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

    Authors: Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne‐Rauzy, Ghulam Mufti, Moshe Mittelman, Petra Muus, Peter A.W. te Boekhorst, Guillermo Sanz, Consuelo del Cañizo, Agnès Guerci‐Bresler, Lars Nilsson, Uwe Platzbecker, Michael Lübbert, Bruno Quesnel, Mario Cazzola, Arnold Ganser, David Bowen, Brigitte Schlegelberger, Carlo Aul, Robert Knight, John Francis, Tommy Fu, Eva Hellström‐Lindberg, for the MDS-004 Lenalidomide del5q Study Group - Blood 2011 cited by 480

  20. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

    Authors: Felicitas Thol, Sofia Kade, Carola Schlarmann, Patrick Löffeld, Michael Morgan, Jürgen Krauter, Marcin W. Włodarski, Britta Kölking, Martin Wichmann, Kerstin Görlich, Gudrun Göhring, Gesine Bug, Oliver G. Ottmann, Charlotte M. Niemeyer, Wolf‐Karsten Hofmann, Brigitte Schlegelberger, Arnold Ganser, Michael Heuser - Blood 2012 cited by 418

  21. Disease evolution and outcomes in familial AML with germline CEBPA mutations

    Authors: Kiran Tawana, Jun Wang, Aline Renneville, Csaba Bödör, Robert K. Hills, Chey Loveday, Aleksandar Savić, Frederik W. van Delft, Jennifer Treleaven, Panayiotis Georgiades, Elizabeth Uglow, Norio Asou, Naokuni Uike, Maruša Debeljak, Janez Jazbec, Philip Ancliff, Rosemary E. Gale, Xavier Thomas, Valérie Mialou, Konstanze Döhner, Lars Bullinger, Beatrice U. Mueller, Thomas Pabst, Matthias Stelljes, Brigitte Schlegelberger, Eva Wozniak, Sameena Iqbal, Jessica Okosun, Shamzah Araf, Anne-Katrine Frank, Felicia B. Lauridsen, Bo Porse, Claus Nerlov, Carolyn Owen, Inderjeet Dokal, John G. Gribben, Matthew L. Smith, Claude Preudhomme, Claude Chelala, Jamie Cavenagh, Jude Fitzgibbon - Blood 2015 cited by 194

  22. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

    Authors: Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, Markus Pfirrmann, Lida Kalmanti, Sébastien Rinaldetti, Katharina Kohlbrenner, Claudia Haferlach, Brigitte Schlegelberger, Alice Fabarius, Wolfgang Seifarth, Birgit Spieß, Patrick Wuchter, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, Christoph Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Andreas Burchert, Tim H. Brümmendorf, Jörg Hasford, Andreas Hochhaus, Susanne Saußele, Michele Baccarani, for the SAKK and the German CML Study Group, Ludwig Fischer von Weikersthal, Markus Hahn, Günter Schlimok, Dietmar Reichert, Jan Janßen, Uwe M. Martens, Peter Majunke, Peter Reichert, Kai Neben, Stefan Korsten, Ch. Scholz, Bernd Oldenkott, Jörg Heßling, D. Kingreen, Christian Sperling, C. Schelenz, I. W. Blau, A. Urmersbach, W. D. Ludwig, Philipp le Coutre, R. Arnold, Maike de Wit, Antonio Pezzutto, E. Schäfer, Roland Schroers, A. Lochter, Dirk Behringer, Y. Ko, St. Weidenhöfer, Walter Verbeek, Peter Brossart, Guido Trenn, W Pommerien, J. Krauter, G. Döering, H. Munzinger, C. Diekmann, Bernd Hertenstein, Sebastian Stier, F. Möller-Faßbender, Mathias Hänel, T. Zöller, C. Lamberti, Babette Koch, A. Henzel, Siegfried Wagner, A. Schmalenbach, M. Hoffknecht, Gerhard Ehninger, Alexander Kiani, Thomas Illmer, Carlo Aul, Michael Flaßhove, F. Henneke, M. Simon, Lothar Müller, Heiko Becker, R. F. Janz, Michael J. Eckart, Roland J. Fuchs, Frank Schlegel, Mohammad Amen Wattad, R. Rudolph, Dietrich W. Beelen, A Lindemann, D. Linck, Wassman, Elke Jäger, Salah‐Eddin Al‐Batran, T Reiber, Cornelius F. Waller, Heinz‐Gert Hoeffkes, L.S. Schulz and 154 more - Leukemia 2020 cited by 92

  23. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

    Authors: Ed Satterwhite, Takashi Sonoki, Tony G. Willis, Lana Harder, Rachael Nowak, Emma Arriola, Hui Liu, Helen P. Price, Stefan Gesk, Doris Steinemann, Brigitte Schlegelberger, David Oscier, Reiner Siebert, Philip W. Tucker, Martin J.S. Dyer - Blood 2001 cited by 313

  24. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications

    Authors: Felicitas Thol, Robin Bollin, Marten Gehlhaar, Carolin Walter, Martin Dugas, Karl Josef Suchanek, Aylin Kirchner, Liu Huang, Anuhar Chaturvedi, Martin Wichmann, Lutz Wiehlmann, Rabia Shahswar, Frédérik Damm, Gudrun Göhring, Brigitte Schlegelberger, Richard F. Schlenk, Konstanze Döhner, Hartmut Döhner, Jürgen Krauter, Arnold Ganser, Michael Heuser - Blood 2013 cited by 204